Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Completed 3Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 11NIH 3INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Papillomavirus Infections 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Colposcopy × Clear all
NCT02634190 2024-02-28

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

Hologic Deutschland GmbH

Completed
10,000 enrolled

Papillomavirus Infections

NCT02267876 2021-02-08

Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

Becton, Dickinson and Company

Completed
6,730 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01944722 2018-06-12

Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

Becton, Dickinson and Company

Phase NA Completed
33,858 enrolled 25 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡